Cue Biopharma Inc. is a biotechnology company focusing on developing novel immunotherapies to treat cancer and autoimmune diseases. The company utilizes its proprietary platform technology to design and engineer therapeutic proteins, enabling the precise modulation of T cell activity. With a strong pipeline of candidates, Cue Biopharma aims to make a significant impact in the field of immune-oncology.
Notification